Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Edlin BR, Seal KH, Lorvick J, Kral AH, Ciccarone DH, Moore LD, Lo B.

N Engl J Med. 2001 Jul 19;345(3):211-5. No abstract available.

PMID:
11463019
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Treatment of chronic hepatitis C in active drug users.

Davis GL, Rodrigue JR.

N Engl J Med. 2001 Jul 19;345(3):215-7. No abstract available. Erratum in: N Engl J Med 2001 Dec 6;345(23):1716.

PMID:
11463020
[PubMed - indexed for MEDLINE]
3.

The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.

Hopwood M, Treloar C.

Int J Drug Policy. 2007 Oct;18(5):374-80. Epub 2007 Jan 23.

PMID:
17854725
[PubMed - indexed for MEDLINE]
4.

[Treatment of hepatitis C in intravenous drug users].

Filoche B.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B252-6. Review. French. No abstract available.

PMID:
12180298
[PubMed - indexed for MEDLINE]
5.

[Hepatitis C and drug use: epidemiology, screening, natural history and treatment].

Lucidarme D.

Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B112-20. Review. French. No abstract available.

PMID:
12180278
[PubMed - indexed for MEDLINE]
6.

Enhancing hepatitis C treatment uptake and outcomes for injection drug users.

Dore GJ.

Hepatology. 2007 Jan;45(1):3-5. No abstract available.

PMID:
17187427
[PubMed - indexed for MEDLINE]
7.

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA.

Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S276-85. Review.

PMID:
15768335
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Initiation of methamphetamine abuse during interferon treatment.

Lampinen TM, Greatheart MS, Schilder AJ, Kowdley K.

Am J Psychiatry. 2007 Sep;164(9):1439. No abstract available.

PMID:
17728435
[PubMed - indexed for MEDLINE]
9.

Elimination on the agenda for hepatitis C.

Burki T.

Lancet Infect Dis. 2014 Jun;14(6):452-3. No abstract available.

PMID:
24971446
[PubMed - indexed for MEDLINE]
10.

Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.

Wiegand J.

J Gastroenterol Hepatol. 2008 Dec;23(12):1782-4. doi: 10.1111/j.1440-1746.2008.05698.x. No abstract available.

PMID:
19120870
[PubMed - indexed for MEDLINE]
11.

Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?

Soriano V, Pérez-Olmeda M, Ríos P, Núñez M, García-Samaniego J, González-Lahoz J.

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):465-6. No abstract available.

PMID:
12640209
[PubMed - indexed for MEDLINE]
12.

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C.

Jack K, Willott S, Manners J, Varnam MA, Thomson BJ.

Aliment Pharmacol Ther. 2009 Jan;29(1):38-45. doi: 10.1111/j.1365-2036.2008.03872.x. Epub 2008 Oct 13.

PMID:
18945252
[PubMed - indexed for MEDLINE]
13.

Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.

Nguyen OK, Dore GJ, Kaldor JM, Hellard ME; ATAHC Protocol Steering Committee.

Int J Drug Policy. 2007 Oct;18(5):447-51. Epub 2007 Feb 21.

PMID:
17854736
[PubMed - indexed for MEDLINE]
14.

Treatment of hepatitis C in injection drug users.

Scott LD.

Am J Gastroenterol. 2005 Jan;100(1):5-7. No abstract available.

PMID:
15654772
[PubMed - indexed for MEDLINE]
15.

Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users.

Swan T, Curry J.

Hepatology. 2009 Jul;50(1):323-4; author reply 324-5. doi: 10.1002/hep.23077. No abstract available.

PMID:
19554546
[PubMed - indexed for MEDLINE]
16.

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.

Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA; Study to Reduce Intravenous Exposures Project Team.

Clin Infect Dis. 2006 Mar 1;42(5):669-72. Epub 2006 Jan 20. Erratum in: Clin Infect Dis. 2006 Jun 15;42(12):1818.

PMID:
16447112
[PubMed - indexed for MEDLINE]
Free Article
17.

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.

Grebely J, Knight E, Genoway KA, Viljoen M, Khara M, Elliott D, Gallagher L, Storms M, Raffa JD, DeVlaming S, Duncan F, Conway B.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):270-7.

PMID:
20425880
[PubMed - indexed for MEDLINE]
18.

Injection drug users can be effectively treated for hepatitis C.

Stancliff S.

Am Fam Physician. 2011 Mar 15;83(6):647; author reply 648. No abstract available.

PMID:
21404974
[PubMed - indexed for MEDLINE]
Free Article
19.

Prisons, prisoners, and hepatitis C.

Ferguson L, Batey R.

J Gastroenterol Hepatol. 2010 Jul;25(7):1184-6. doi: 10.1111/j.1440-1746.2010.06357.x. No abstract available.

PMID:
20594243
[PubMed - indexed for MEDLINE]
20.

Current challenges in hepatitis C.

Swan T.

Res Initiat Treat Action. 2004 Fall;10(2):17-20. No abstract available.

PMID:
15828096
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk